Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Photobiomodulation in Children With Localized Scleroderma

NCT: NCT06621628 · COMPLETED

NCT IDNCT06621628
StatusCOMPLETED
Start Date2025-04-10
Completion2025-11-05

Brief Summary

to evaluate the efficacy of the Polarized light therapy and Hand Grip Strengthening exercises in patients with CREST syndrome

Frequently Asked Questions

What is Photobiomodulation in Children With Localized Scleroderma?

Photobiomodulation in Children With Localized Scleroderma is a clinical trial registered under NCT06621628. Current status: COMPLETED.

What is the status of NCT06621628?

The current status of NCT06621628 (Photobiomodulation in Children With Localized Scleroderma) is: COMPLETED.

When did Photobiomodulation in Children With Localized Scleroderma start?

Photobiomodulation in Children With Localized Scleroderma started on 2025-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑